KLBF – Anticipates 12% VAT increase on medicine prices

KLBF – Anticipates 12% VAT increase on medicine prices Kalbe Farma (KLBF) is preparing for the potential impact of a 12% VAT increase on the prices of medicines. Currently, medicines prices remain affordable, supported by stable raw material costs. KLBF will continue striving to maintain its margins to ensure stable performance. Note that, KLBF recorded revenue of IDR24.23 tn (+7.4% yoy) and net profit of IDR2.37 tn (+15.2% yoy) in 9M24. (Source : Bisnis Indonesia)